Results 11 to 20 of about 4,517,311 (361)

Anticoagulant Therapy Is Associated With Decreased Long-Term Mortality in Splenic Infarction Patients: A Multicenter Study

Frontiers in Medicine, 2021
Background: Patients with splenic infarction (SI) are associated with a prothrombotic state and are vulnerable to subsequent thromboembolic complications. However, due to its rarity, there is no established treatment modality in this population. We aimed
Chieh-Ching Yen, Chieh-Ching Yen, Chih-Kai Wang, Chih-Kai Wang, Chung-Hsien Chaou, Chung-Hsien Chaou, Chung-Hsien Chaou, Shou-Yen Chen, Shou-Yen Chen, Shou-Yen Chen, Jhe-Ping Lin, Jhe-Ping Lin, Chip-Jin Ng, Chip-Jin Ng   +13 more
doaj   +1 more source

Assessment of adherence level of patients on anticoagulant therapy in a tertiary healthcare facility in Uyo, Nigeria

Ibom Medical Journal, 2021
Background: Anticoagulants are highly effective in preventing venous thromboembolism and remains the main stay of treatment. However, strict adherence to medication is essential for maximizing treatment. Objectives: the objectives of this study, were to
Ekwere TA, Ekanem AM, Benson SM
doaj   +1 more source

Thromboembolic risk and anticoagulant therapy in COVID‐19 patients: emerging evidence and call for action

British Journal of Haematology, 2020
Emerging evidence shows that severe coronavirus disease 2019 (COVID‐19) can be complicated with coagulopathy, namely disseminated intravascular coagulation, which has a rather prothrombotic character with high risk of venous thromboembolism.
A. Kollias, K. Kyriakoulis, E. Dimakakos, G. Poulakou, G. Stergiou, K. Syrigos   +5 more
semanticscholar   +1 more source

Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum

Journal of Thrombosis and Thrombolysis, 2020
Coronavirus disease 2019 (COVID-19) is a viral infection that can, in severe cases, result in cytokine storm, systemic inflammatory response and coagulopathy that is prognostic of poor outcomes. While some, but not all, laboratory findings appear similar
G. Barnes, Allison E. Burnett, Arthur L. Allen, Marilyn Blumenstein, N. Clark, A. Cuker, William E Dager, S. Deitelzweig, S. Ellsworth, D. Garcia, S. Kaatz, Tracy Minichiello   +11 more
semanticscholar   +1 more source

Sepsis-related coagulopathy treatment based on the disseminated intravascular coagulation diagnostic criteria: a post-hoc analysis of a prospective multicenter observational study

Journal of Intensive Care, 2023
Background The development of disseminated intravascular coagulation (DIC) in patients with sepsis has been repeatedly confirmed as a factor associated with poor prognosis.
Takeshi Wada, Kazuma Yamakawa, Daijiro Kabata, Toshikazu Abe, Seitaro Fujishima, Shigeki Kushimoto, Toshihiko Mayumi, Hiroshi Ogura, Daizoh Saitoh, Atsushi Shiraishi, Yasuhiro Otomo, Satoshi Gando, the JAAM FORECAST Group   +12 more
doaj   +1 more source

Clinical study of anticoagulant therapy in patients with severe coronavirus disease: A single-center retrospective analysis

Vascular Investigation and Therapy, 2021
OBJECTIVE: The prognosis of COVID-19 is related to thrombotic events. This study investigated prognostic risk factors, anticoagulant therapy effects, and potential instruction of treatment or prognostic with D-dimer in patients with severe COVID-19 ...
Peng Zhou, Chuan-Qi Cai, Jin-Song Li, Huan-Zong Jiang, Zun-Xiang Ke, Shan Zhang, Zhong-Jian Wang, Chao Yang, Qin Li, Yi-Qing Li   +9 more
doaj   +1 more source

Anticoagulation after typical atrial flutter ablation [PDF]

Клиническая практика, 2023
The specifics of the anticoagulant therapy after radiofrequency ablation of the cavotricuspid isthmus have not been sufficiently studied, therefore, the recommendations for prescribing the anticoagulant therapy usually do not distinguish between atrial ...
Irina A. Bulavina, Igor A. Khamnagadaev, Igor I. Khamnagadaev, Mikhail L. Kokov, Aleksandr V. Troitskiy, Aleksandr S. Zotov, Leonid S. Kokov, Maria A. Shkolnikova   +7 more
doaj   +1 more source

Ischemic Stroke despite Oral Anticoagulant Therapy in Patients with Atrial Fibrillation

Annals of Neurology, 2020
It is not known whether patients with atrial fibrillation (AF) with ischemic stroke despite oral anticoagulant therapy are at increased risk for further recurrent strokes or how ongoing secondary prevention should be managed.
D. Seiffge, G. D. De Marchis, M. Koga, M. Paciaroni, D. Wilson, M. Cappellari, Kosmas Macha, G. Tsivgoulis, G. Ambler, S. Arihiro, L. Bonati, B. Bonetti, B. Kallmünzer, K. Muir, P. Bovi, H. Gensicke, M. Inoue, S. Schwab, S. Yaghi, Martin M. Brown, P. Lyrer, Masahito Takagi, Monica Acciarrese, H. Jager, A. Polymeris, K. Toyoda, M. Venti, C. Traenka, H. Yamagami, A. Alberti, S. Yoshimura, V. Caso, S. Engelter, D. Werring   +33 more
semanticscholar   +1 more source

Impact of Preinjury Antithrombotic Therapy on 30–Day Mortality in Older Patients Hospitalized With Traumatic Brain Injury (TBI)

Frontiers in Neurology, 2021
Objective: Elderly patients are frequently in need of antithrombotic therapy for reducing thrombotic events. The association between antithrombotic drugs and survival after traumatic brain injury (TBI) is, nevertheless, unclear.Methods: This ...
Pål Rønning, Eirik Helseth, Eirik Helseth, Ola Skaansar, Cathrine Tverdal, Cathrine Tverdal, Nada Andelic, Nada Andelic, Rahul Bhatnagar, Mathias Melberg, Nils Oddvar Skaga, Mads Aarhus, Sigrun Halvorsen, Sigrun Halvorsen, Ragnhild Helseth   +14 more
doaj   +1 more source

Anticoagulant therapy for splanchnic vein thrombosis: A systematic review and meta-analysis.

Blood, 2020
Treatment of splanchnic vein thrombosis (SVT) is challenging and evidence to guide therapeutic decisions remains scarce. The objective of this systematic review and meta-analysis was to determine the efficacy and safety of anticoagulant therapy for SVT ...
Emanuele Valeriani, M. Di Nisio, Nicoletta Riva, O. Cohen, J. García‐Pagán, M. Magaz, E. Porreca, W. Ageno   +7 more
semanticscholar   +1 more source